JPS6146476B2 - - Google Patents
Info
- Publication number
- JPS6146476B2 JPS6146476B2 JP56111458A JP11145881A JPS6146476B2 JP S6146476 B2 JPS6146476 B2 JP S6146476B2 JP 56111458 A JP56111458 A JP 56111458A JP 11145881 A JP11145881 A JP 11145881A JP S6146476 B2 JPS6146476 B2 JP S6146476B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- compound
- reaction
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 150000007978 oxazole derivatives Chemical class 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- -1 β-naphthyl group Chemical group 0.000 description 39
- 150000001875 compounds Chemical class 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VTOVIJQMFYQNSX-UHFFFAOYSA-N 1-(4-methylphenoxy)propan-2-ol Chemical compound CC(O)COC1=CC=C(C)C=C1 VTOVIJQMFYQNSX-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- CUFXMPWHOWYNSO-UHFFFAOYSA-N 2-[(4-methylphenoxy)methyl]oxirane Chemical compound C1=CC(C)=CC=C1OCC1OC1 CUFXMPWHOWYNSO-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004861 4-isopropyl phenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- DGEYTDCFMQMLTH-UHFFFAOYSA-N methanol;propan-2-ol Chemical compound OC.CC(C)O DGEYTDCFMQMLTH-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は新規なオキサゾール誘導体に関する。
本発明のオキサゾール誘導体は文献未載の新規
化合物であり、下記一般式(1)で表わされる。
〔式中Rは低級アルキル基、フエニル基、ナフチ
ル基、又は置換基として低級アルキル基、ハロ低
級アルキル基、低級アルコキシ基、低級アルキル
チオ基、ニトロ基、シアノ基、ハロゲン原子及び
フエニル基から成る群から選ばれた基を1〜3個
有することのあるフエニル基を示す。Yは酸素原
子又は硫黄原子を示す。nは2又は3を示す。〕
上記一般式(1)で表わされる化合物は局所麻酔作
用、血小板凝集阻止作用を有し、局所麻酔薬、血
栓症の予防乃至治療薬等として有用である。
上記一般式(1)において示される各基は具体的に
は以下の通りである。
低級アルキル基……メチル、エチル、プロピル、
イソプロピル、ブチル、tert−ブチル、ペンチ
ル、ヘキシル基等。
ナフチル基……α−ナフチル基、β−ナフチル基
等。
ハロゲン原子……弗素原子、塩素原子、臭素原
子、沃素原子等。
ハロ低級アルキル基……トリフルオロメチル、ト
リブロモメチル、トリクロロメチル、トリヨー
ドメチル、2−フルオロエチル、2・2−ジフ
ルオロエチル、2・2・2−トリフルオロエチ
ル基等。
低級アルコキシ基……メトキシ、エトキシ、プロ
ポキシ、イソプロポキシ、ブトキシ、tert−ブ
トキシ、ペンチルオキシ、ヘキシルオキシ基
等。
低級アルキルチオ基……メチルチオ、エチルチ
オ、プロピルチオ、イソプロピルチオ、ブチル
チオ、tert−ブチルチオ、ペンチルチオ、ヘキ
シルチオ基等。
置換基としてアルキル基、ハロ低級アルキル
基、低級アルコキシ基、低級アルキルチオ基、ニ
トロ基、シアノ基、ハロゲン原子及びフエニル基
から成る群から選ばれた基を1〜3個有すること
のあるフエニル基……フエニル、2−メチルフエ
ニル、3−メチルフエニル、4−メチルフエニ
ル、4−エチルフエニル、4−プロピルフエニ
ル、4−イソプロピルフエニル、3・4−ジメチ
ルフエニル、2・3・4−トリメチルフエニル、
2・3・5−トリメチルフエニル、2・3・6−
トリメチルフエニル、2−トリフルオロメチルフ
エニル、3−トリフルオロメチルフエニル、4−
トリフルオロメチルフエニル、3−トリブロモメ
チルフエニル、3−トリクロロメチル−フエニ
ル、3−トリヨードメチルフエニル、2−メトキ
シフエニル、3−メトキシフエニル、4−メトキ
シフエニル、4−エトキシフエニル、4−プロポ
キシフエニル、4−イソプロポキシフエニル、4
−ブトキシフエニル、4−tert−ブトキシフエニ
ル、2−メチルチオフエニル、3−メチルチオフ
エニル、4−メチルチオフエニル、2−メチル−
4−メチルチオフエニル、3−メチル−4−メチ
ルチオフエニル、2−ニトロフエニル、3−ニト
ロフエニル、4−ニトロフエニル、2−シアノフ
エニル、3−シアノフエニル、4−シアノフエニ
ル、2−クロロフエニル、3−フルオロフエニ
ル、4−ブロムフエニル、2・3−ジクロロフエ
ニル、2・4−ジクロロフエニル、2・4−ジフ
ルオロフエニル、2・4−ジブロモフエニル、2
−フエニルフエニル、3−フエニルフエニル、4
−フエニルフエニル基等。
本発明の化合物は種々の方法により製造される
が、その好ましい一例を挙げれば以下に示す方法
により製造される。
〔式中Xは、ハロゲン原子、R′はハロゲン原子を
示す。R及びYは前記に同じ。〕
即ち本発明化合物は、一般式(2)で表わされる公
知のハロゲン化合物又は一般式(3)で表わされる公
知のエポキシ化合物と一般式(4)で表わされる公知
のジアミンとを反応させ、次いで得られる一般式
(5)で表わされる化合物に二硫化炭素を反応させ、
更に得られる一般式(6)で表わされる化合物に一般
式(7)で表わされるハロゲン化アルキルを反応さ
せ、最後に得られる一般式(8)で表わされる化合物
に塩基を作用させることにより製造される。
一般式(2)又は(3)の化合物と一般式(4)の化合物と
の反応は通常適当な溶媒中にて行なわれる。溶媒
としては反応に悪影響を及ぼさないものであれば
各種の有機溶媒も広く使用でき、例えばメタノー
ル、エタノール、イソプロパノール等の低級アル
コール類、ジエチルエーテル、テラヒドロフラ
ン、ジオキサン等のエーテル類、ベンゼン、トル
エン、キシレン等の芳香族炭化水素類、酢酸エチ
ル等を挙げることができる。一般式(2)又は(3)の化
合物と一般式(4)の化合物との使用割合としては特
に限定されず広い範囲内で適宜選択し得るが、通
常前者に対して後者を少なくとも等モル量程度、
好ましくは5〜7倍モル量用いるのがよい。該反
応は室温及び加温下のいずれでも行ない得るが、
溶媒の沸点付近にて反応は好適に進行し、一般に
1〜10時間程度にて反応は終了する。
一般式(5)の化合物と二硫化炭素との反応は、無
溶媒又は適当な溶媒中にて行なわれる。溶媒とし
ては反応に悪影響を及ぼさない限り各種の有機溶
媒を広く使用でき、具体的には前記低級アルコー
ル類、前記エーテル類、前記芳香族炭化水素類等
を例示できる。これらの溶媒のうちでも低級アル
コール類が特に好適である。一般式(5)の化合物と
二硫化炭素との使用割合としては特に限定がな
く、広い範囲内で適宜選択すればよいが、通常前
者に対して後者を少なくとも等モル量程度、好ま
しくは等モル〜2倍モル量程度用いるのがよい。
反応温度としては特に限定がなく氷冷下、室温下
及び加温下のいずれでも行ない得るが、通常は室
温付近で1〜5時間程度反応させた後、溶媒を除
去し、次いで残留物を100〜130℃程度まで加温す
るのがよい。斯くして一般式(6)の化合物が生成す
る。
一般式(6)の化合物と一般式(7)の化合物との反応
は一般に有機溶媒中にて行なわれる。有機溶媒と
しては反応に悪影響を及ぼさないものを広く使用
でき、具体的にはメタノール、エタノール等の低
級アルコール類、四塩化炭素、塩化メチレン、ク
ロロホルム等のハロゲン化炭化水素類、アセト
ン、テトラヒドロフラン等を例示できる。一般式
(6)の化合物と一般式(7)の化化合物との使用割合と
しては特に限定されず広い範囲内で適宜選択する
ことができるが、通常前者に対して後者を等モル
〜10倍モル量程度、好ましくは1.5〜3倍モル量
程度用いるのがよい。該反応は冷却下、室温化及
び加温下のいずれにおいても進行するが、好まし
くは室温付近にて行なわれる。反応時間は通常1
〜10時間程度である。
一般式(8)の化合物に塩基を作用させるに際して
は、反応に悪影響を与えない有機溶媒中、例えば
メタノール、エタノール、イソプロパノール等の
低級アルコール類、アセトン、テトラヒドロフラ
ン等の溶媒中又は水中にて行なうのがよい。塩基
としては従来公知のものを広く使用でき、例えば
アンモニア、トリエチルアミン等の有機塩基類、
炭酸ナトリウム、炭酸カリウム、重炭酸ナトリウ
ム等の無機塩基を挙げることができる。斯かる塩
基の使用量としては特に限定されないが、通常一
般式(8)の化合物に対して等モル〜50倍モル量、好
ましくは等モル〜5倍モル量用いられる。該反応
は冷却下、室温下及び加温化のいずれでも行ない
得るが、室温〜100℃程度にて好適に進行する。
また反応時間は通常1〜20時間程度である。斯く
して本発明の化合物が製造される。
斯くして得られる本発明の化合物は、慣用の分
離手段、例えば溶媒抽出、再結晶、カラムクロマ
トグラフイー等により反応混合物から容易に単離
精製される。
本発明化合物は、通常の薬理的に許容し得る酸
と容易に塩を形成し得る。斯る酸としては、例え
ば硫酸、硝酸、塩酸、臭化水素酸等の無機酸、酢
酸、p−トルエンスルホン酸、エタンスルホン
酸、シユウ酸、マレイン酸、コハク酸、安息香酸
等の有機酸が挙げられる。
次に本発明の化合物について参考例及び実施例
を挙げさらに具体的に示すが、本発明化合物はこ
れらに限定されるものではない。
参考例 1
エチレンジアミン84gをメタノール300mlに加
え、60〜70℃に加温しつつ、2・3−エポキシプ
ロピル(4−メチルフエニル)エーテル30gのメ
タノール溶液100mlを1時間にわたつて滴下す
る。滴下終了後、2時間還流し、次いで溶媒及び
過剰のエチレンジアミンを減圧下に留去すると、
残渣として1−(2−アミノエチルアミノ)−3−
(4−メチルフエノキシ)−2−プロパノールが得
られる。
上記で得られる1−(2−アミノエチルアミ
ノ)−3−(4−メチルフエノキシ)−2−プロパ
ノールを単離することなく、この残渣をエタノー
ル300mlに溶解し、二硫化炭素20mlを加えると沈
殿物を生成する。1時間放置した後、デカンテー
シヨンで沈殿物を分取し、油浴上にて徐々に120
℃まで加温し、更に120℃で1時間加温を続け
る。この反応生成物に熱時、イソプロパノール
200mlを加える。冷後析出する結晶を取し、イ
ソプロパノールメタノールより再結晶して融点
141〜142℃の1−〔2−ヒドロキシ−3−(4−メ
チルフエノキシ)プロピル〕−2−イミダゾリジ
ンチオン31gを得る。
実施例 1
2・3・5・6−テトラヒドロ−2−(4−メ
チルフエノキシメチル)イミダゾ〔2・1−
b〕オキサゾールの製造
1−〔2−ハイドロキシ−3−(4−メチルフエ
ノキシ)プロピル〕−2−イミダゾリジンチオン
5g、ヨー化メチル3mlをアセトン100ml中に加
え、室温下3時間撹拌する。析出した結晶をろ取
し、この結晶を炭酸カリ5gを溶解した水200ml
と酢酸エチルエステル200mlの混合液中に加え10
分間撹拌する。有機層を分取し、乾燥
(MgSO4)、濃縮して得られる油状物質にイソプ
ロピルアルコール200mlを加えて3時間還流す
る。反応液を濃縮して得られる結晶を酢酸メチル
エステル−イソプロピルエーテルより再結晶して
2・3・5・6−テトラヒドロ−2−(4−メチ
ルフエノキシメチル)イミダゾ〔2・1〕オキサ
ゾールを得る。
融点115−117℃
実施例1と同様にして下記第1表に記載の実施
例2〜8の化合物を得る。
The present invention relates to novel oxazole derivatives. The oxazole derivative of the present invention is a novel compound that has not been described in any literature, and is represented by the following general formula (1). [In the formula, R is a lower alkyl group, a phenyl group, a naphthyl group, or a group consisting of a lower alkyl group, a halo-lower alkyl group, a lower alkoxy group, a lower alkylthio group, a nitro group, a cyano group, a halogen atom, and a phenyl group as a substituent. Indicates a phenyl group that may have 1 to 3 groups selected from Y represents an oxygen atom or a sulfur atom. n represents 2 or 3. ] The compound represented by the above general formula (1) has a local anesthetic effect and a platelet aggregation inhibiting effect, and is useful as a local anesthetic, a prophylactic or therapeutic agent for thrombosis, and the like. Specifically, each group shown in the above general formula (1) is as follows. Lower alkyl group...methyl, ethyl, propyl,
Isopropyl, butyl, tert-butyl, pentyl, hexyl groups, etc. Naphthyl group...α-naphthyl group, β-naphthyl group, etc. Halogen atoms: fluorine atoms, chlorine atoms, bromine atoms, iodine atoms, etc. Halo lower alkyl group: trifluoromethyl, tribromomethyl, trichloromethyl, triiodomethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl group, etc. Lower alkoxy groups: methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, hexyloxy groups, etc. Lower alkylthio groups: methylthio, ethylthio, propylthio, isopropylthio, butylthio, tert-butylthio, pentylthio, hexylthio groups, etc. A phenyl group that may have 1 to 3 groups selected from the group consisting of an alkyl group, a halo-lower alkyl group, a lower alkoxy group, a lower alkylthio group, a nitro group, a cyano group, a halogen atom, and a phenyl group as a substituent... ... phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 4-ethylphenyl, 4-propylphenyl, 4-isopropylphenyl, 3,4-dimethylphenyl, 2,3,4-trimethylphenyl,
2,3,5-trimethylphenyl, 2,3,6-
Trimethylphenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-
Trifluoromethylphenyl, 3-tribromomethylphenyl, 3-trichloromethyl-phenyl, 3-triiodomethylphenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 4-ethoxy Phenyl, 4-propoxyphenyl, 4-isopropoxyphenyl, 4
-butoxyphenyl, 4-tert-butoxyphenyl, 2-methylthiophenyl, 3-methylthiophenyl, 4-methylthiophenyl, 2-methyl-
4-methylthiophenyl, 3-methyl-4-methylthiophenyl, 2-nitrophenyl, 3-nitrophenyl, 4-nitrophenyl, 2-cyanophenyl, 3-cyanophenyl, 4-cyanophenyl, 2-chlorophenyl, 3-fluorophenyl, 4-bromphenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 2,4-difluorophenyl, 2,4-dibromophenyl, 2
-Phenylphenyl, 3-Phenylphenyl, 4
-phenyl phenyl group, etc. The compound of the present invention can be manufactured by various methods, and one preferred example thereof is the method shown below. [In the formula, X represents a halogen atom, and R' represents a halogen atom. R and Y are the same as above. ] That is, the compound of the present invention can be obtained by reacting a known halogen compound represented by general formula (2) or a known epoxy compound represented by general formula (3) with a known diamine represented by general formula (4), and then The resulting general formula
Reacting the compound represented by (5) with carbon disulfide,
Furthermore, it is produced by reacting the obtained compound represented by general formula (6) with an alkyl halide represented by general formula (7), and finally reacting the obtained compound represented by general formula (8) with a base. Ru. The reaction between the compound of general formula (2) or (3) and the compound of general formula (4) is usually carried out in a suitable solvent. Various organic solvents can be used as long as they do not adversely affect the reaction, such as lower alcohols such as methanol, ethanol, and isopropanol, ethers such as diethyl ether, terahydrofuran, and dioxane, benzene, and toluene. , aromatic hydrocarbons such as xylene, ethyl acetate, and the like. The ratio of the compound of general formula (2) or (3) and the compound of general formula (4) to be used is not particularly limited and can be appropriately selected within a wide range, but usually at least an equimolar amount of the latter to the former. degree,
It is preferable to use 5 to 7 times the molar amount. The reaction can be carried out either at room temperature or under heating,
The reaction proceeds suitably near the boiling point of the solvent, and is generally completed in about 1 to 10 hours. The reaction between the compound of general formula (5) and carbon disulfide is carried out without a solvent or in a suitable solvent. As the solvent, a wide variety of organic solvents can be used as long as they do not adversely affect the reaction, and specific examples include the lower alcohols, ethers, aromatic hydrocarbons, and the like. Among these solvents, lower alcohols are particularly preferred. The ratio of the compound of general formula (5) and carbon disulfide to be used is not particularly limited and may be appropriately selected within a wide range, but usually the latter is used in at least an equimolar amount, preferably an equimolar amount, relative to the former. It is preferable to use about 2 to 2 times the molar amount.
The reaction temperature is not particularly limited and can be carried out under ice-cooling, at room temperature, or under heating, but usually after reacting at around room temperature for about 1 to 5 hours, the solvent is removed and the residue is heated to 100% It is best to heat it to around 130℃. In this way, a compound of general formula (6) is produced. The reaction between the compound of general formula (6) and the compound of general formula (7) is generally carried out in an organic solvent. As the organic solvent, a wide range of organic solvents can be used that do not adversely affect the reaction, and specific examples include lower alcohols such as methanol and ethanol, halogenated hydrocarbons such as carbon tetrachloride, methylene chloride, and chloroform, acetone, and tetrahydrofuran. I can give an example. general formula
The ratio of the compound of (6) and the compound of general formula (7) is not particularly limited and can be appropriately selected within a wide range, but usually the latter is used in an amount equivalent to 10 times the molar amount of the former. It is preferable to use about 1.5 to 3 times the molar amount. The reaction proceeds either under cooling, at room temperature, or under heating, but is preferably carried out at around room temperature. The reaction time is usually 1
~10 hours. When reacting the compound of general formula (8) with a base, it may be carried out in an organic solvent that does not adversely affect the reaction, such as lower alcohols such as methanol, ethanol, isopropanol, acetone, tetrahydrofuran, etc., or in water. Good. As the base, a wide range of conventionally known bases can be used, such as organic bases such as ammonia and triethylamine;
Mention may be made of inorganic bases such as sodium carbonate, potassium carbonate, sodium bicarbonate and the like. The amount of such a base to be used is not particularly limited, but it is usually used in an equimolar to 50-fold molar amount, preferably an equimolar to 5-fold molar amount, relative to the compound of general formula (8). The reaction can be carried out under cooling, at room temperature, or under heating, but preferably proceeds at room temperature to about 100°C.
Further, the reaction time is usually about 1 to 20 hours. The compound of the present invention is thus produced. The compound of the present invention thus obtained can be easily isolated and purified from the reaction mixture by conventional separation means such as solvent extraction, recrystallization, column chromatography, etc. The compounds of the present invention can easily form salts with common pharmaceutically acceptable acids. Examples of such acids include inorganic acids such as sulfuric acid, nitric acid, hydrochloric acid, and hydrobromic acid, and organic acids such as acetic acid, p-toluenesulfonic acid, ethanesulfonic acid, oxalic acid, maleic acid, succinic acid, and benzoic acid. Can be mentioned. Next, reference examples and examples will be given to further specifically illustrate the compounds of the present invention, but the compounds of the present invention are not limited thereto. Reference Example 1 84 g of ethylenediamine is added to 300 ml of methanol, and while heating the mixture to 60-70°C, 100 ml of a methanol solution of 30 g of 2,3-epoxypropyl (4-methylphenyl) ether is added dropwise over 1 hour. After the dropwise addition was completed, the mixture was refluxed for 2 hours, and then the solvent and excess ethylenediamine were distilled off under reduced pressure.
1-(2-aminoethylamino)-3- as a residue
(4-methylphenoxy)-2-propanol is obtained. Without isolating the 1-(2-aminoethylamino)-3-(4-methylphenoxy)-2-propanol obtained above, this residue was dissolved in 300 ml of ethanol and 20 ml of carbon disulfide was added to form a precipitate. generate. After leaving it for 1 hour, separate the precipitate by decantation and gradually heat it on an oil bath at 120 °C.
℃ and continue heating at 120℃ for 1 hour. When this reaction product is hot, isopropanol
Add 200ml. The crystals that precipitate after cooling are collected and recrystallized from isopropanol methanol to determine the melting point.
31 g of 1-[2-hydroxy-3-(4-methylphenoxy)propyl]-2-imidazolidinethione at 141-142 DEG C. is obtained. Example 1 2.3.5.6-tetrahydro-2-(4-methylphenoxymethyl)imidazo[2.1-
b] Production of oxazole 5 g of 1-[2-hydroxy-3-(4-methylphenoxy)propyl]-2-imidazolidinethione and 3 ml of methyl iodide are added to 100 ml of acetone and stirred at room temperature for 3 hours. Filter the precipitated crystals and add 200 ml of water containing 5 g of potassium carbonate to the crystals.
and ethyl acetate 200ml and add 10
Stir for a minute. The organic layer is separated, dried (MgSO 4 ), and concentrated. 200 ml of isopropyl alcohol is added to the resulting oily substance, and the mixture is refluxed for 3 hours. The crystals obtained by concentrating the reaction solution were recrystallized from methyl acetate-isopropyl ether to obtain 2,3,5,6-tetrahydro-2-(4-methylphenoxymethyl)imidazo[2,1]oxazole. obtain. Melting point: 115 DEG -117 DEG C. Compounds of Examples 2 to 8 listed in Table 1 below are obtained in the same manner as in Example 1.
【表】【table】
【表】
実施例 9
2・3・6・7−テトラヒドロ−2−フエニル
チオメチル−5H−オキサゾロ〔3・2−a〕
ピリミジン・沃化水素酸塩の製造
1−(2−ハイドロキシ−3−フエニルチオプ
ロピル)パーヒドロピリミジン−2−チオン3g
及び沃化メチル3mlをアセトン100mlに加え、室
温下3時間撹拌する。析出する結晶を取し、こ
の結晶をエタノール100ml及び28%アンモニア水
10mlの混合液中に加え、3時間撹拌する。反応液
を濃縮して得られる結晶を酢酸エチルエステルエ
タノールより再結晶して2・3・6・7−テトラ
ヒドロ−2−フエニルチオメチル−5−H−オキ
サゾロ〔3・2−a〕ピリミジン・沃化素酸塩を
得る。融点157〜159℃
実施例9と同様にして下記第2表に記載の実施
例10〜15の化合物を得る。[Table] Example 9 2,3,6,7-tetrahydro-2-phenylthiomethyl-5H-oxazolo [3,2-a]
Production of pyrimidine/hydriodide 1-(2-hydroxy-3-phenylthiopropyl)perhydropyrimidine-2-thione 3g
and 3 ml of methyl iodide were added to 100 ml of acetone, and the mixture was stirred at room temperature for 3 hours. Take the precipitated crystals and add them to 100ml of ethanol and 28% ammonia water.
Add to 10ml of the mixture and stir for 3 hours. The reaction solution was concentrated and the resulting crystals were recrystallized from ethyl acetate ethanol to give 2,3,6,7-tetrahydro-2-phenylthiomethyl-5-H-oxazolo[3,2-a]pyrimidine. Obtain iodide. Melting point: 157-159°C Compounds of Examples 10-15 listed in Table 2 below are obtained in the same manner as in Example 9.
Claims (1)
ル基、又は置換基として低級アルキル基、ハロ低
級アルキル基、低級アルコキシ基、低級アルキル
チオ基、ニトロ基、シアノ基、ハロゲン原子及び
フエニル基から成る群から選ばれた基を1〜3個
有することのあるフエニル基を示す。Yは酸素原
子又は硫黄原子を示す。nは2又は3を示す。〕 で表わされるオキサゾール誘導体及びその塩。[Claims] 1. General formula [In the formula, R is a lower alkyl group, a phenyl group, a naphthyl group, or a group consisting of a lower alkyl group, a halo-lower alkyl group, a lower alkoxy group, a lower alkylthio group, a nitro group, a cyano group, a halogen atom, and a phenyl group as a substituent. Indicates a phenyl group that may have 1 to 3 groups selected from Y represents an oxygen atom or a sulfur atom. n represents 2 or 3. ] An oxazole derivative represented by these and its salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56111458A JPS5813587A (en) | 1981-07-15 | 1981-07-15 | Oxazole derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56111458A JPS5813587A (en) | 1981-07-15 | 1981-07-15 | Oxazole derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5813587A JPS5813587A (en) | 1983-01-26 |
JPS6146476B2 true JPS6146476B2 (en) | 1986-10-14 |
Family
ID=14561737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56111458A Granted JPS5813587A (en) | 1981-07-15 | 1981-07-15 | Oxazole derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5813587A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0189373U (en) * | 1987-12-03 | 1989-06-13 | ||
JPH0530772U (en) * | 1991-09-30 | 1993-04-23 | 横河電機株式会社 | Frequency signal measuring device |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015006994A (en) * | 2011-10-28 | 2015-01-15 | 大正製薬株式会社 | Dihydroimidazooxazole derivative |
-
1981
- 1981-07-15 JP JP56111458A patent/JPS5813587A/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0189373U (en) * | 1987-12-03 | 1989-06-13 | ||
JPH0530772U (en) * | 1991-09-30 | 1993-04-23 | 横河電機株式会社 | Frequency signal measuring device |
Also Published As
Publication number | Publication date |
---|---|
JPS5813587A (en) | 1983-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100414998B1 (en) | Process for synthesizing COX-2 inhibitors | |
SU615857A3 (en) | Method of obtaining 1,2,4-triazole derivatives or salts thereof | |
EP0026928B1 (en) | 3,4-diarylisoxazol-5-acetic acid compounds, process for preparing the same, and pharmaceuticals containing the same | |
JP2556722B2 (en) | Novel sulfonamide compound | |
JPS6339868A (en) | Di (lower alkyl) phenol derivative | |
JPS58206581A (en) | Novel ring-substituted derivative of pyrogallol | |
HU176897B (en) | Process for preparing 3-/cyanimino/-3-amino-propionitrile derivatives | |
JPS6146476B2 (en) | ||
US4158013A (en) | N-Cyano-N'-alkynyl-N"-2-mercaptoethylguanidines | |
CA1110653A (en) | Optical resolution of amino acids into optical antipodes | |
JP2762430B2 (en) | Preparation of aralkylaminopyrimidines | |
JP2007308510A (en) | Derivative of 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyl chloride, its production method, and its use as synthetic intermediate | |
JPH0475908B2 (en) | ||
JPH0115506B2 (en) | ||
JPH0159273B2 (en) | ||
JPS60226878A (en) | 3-amino-1-(4,5,6,7-tetrahydrobenzothiazolyl)-2-pyrazolines and manufacture | |
JPS6039667B2 (en) | Thiazole derivative | |
US3887568A (en) | Process for piperidine derivatives | |
JPS6112901B2 (en) | ||
JPS62108867A (en) | Production of imidazolyl-methane derivative | |
JPH03215488A (en) | Pyrimidobenzimidazole derivative | |
HU190087B (en) | Process for preparing 3-phenyl-pyrrole derivatives | |
JPS5916879A (en) | Production of n-substituted imidazole | |
JPS604830B2 (en) | Phenyl acetic acid derivative | |
CA1085846A (en) | Process for producing 3-substituted 1,2,4-triazines |